Variable | Before PSM | After PSM | ||||||
---|---|---|---|---|---|---|---|---|
OS | LCSS | OS | LCSS | |||||
Hazard ratio (95% CI) | p | Hazard ratio (95% CI) | p | Hazard ratio (95% CI) | p | Hazard ratio (95% CI) | p | |
Age (versus <60 years) | ||||||||
60–79 years | 0.822 (0.742–0.911) | 0.000 | 0.809 (0.723–0.904) | 0.000 | 0.758 (0.648–0.887) | 0.001 | 0.716 (0.604–0.850) | 0.000 |
≥80 years | 1.007 (0.844–1.201) | 0.938 | 1.059 (0.878–1.277) | 0.548 | 0.962 (0.730–1.267) | 0.781 | 0.977 (0.727–1.313) | 0.876 |
Gender (versus Male) | 1.066 (0.974–1.168) | 0.163 | 1.049 (0.951–1.158) | 0.337 | 1.030 (0.895–1.186) | 0.676 | 1.030 (0.884–1.202) | 0.703 |
Race (versus White) | 1.033 (0.923–1.157) | 0.570 | 1.043 (0.922–1.179) | 0.504 | 1.085 (0.912–1.291) | 0.357 | 1.108 (0.917–1.339) | 0.289 |
Marital status (versus Married) | 1.001 (0.912–1.099) | 0.984 | 0.966 (0.872–1.070) | 0.511 | 1.160 (1.000–1.344) | 0.049 | 1.173 (0.999–1.378) | 0.052 |
Insurance (versus insured) | 0.970 (0.883–1.065) | 0.519 | 0.995 (0.899–1.101) | 0.924 | 0.844 (0.730–0.977) | 0.023 | 0.877 (0.748–1.027) | 0.104 |
Laterality (versus left) | 1.021 (0.929–1.121) | 0.671 | 1.061 (0.958–1.175) | 0.257 | 1.048 (0.906–1.212) | 0.530 | 1.107 (0.943–1.298) | 0.213 |
Location (versus upper lobe) | ||||||||
Lower lobe | 1.025 (0.812–1.294) | 0.834 | 1.027 (0.800–1.317) | 0.835 | 1.137 (0.807–1.601) | 0.463 | 1.076 (0.737–1.570) | 0.706 |
Middle lobe | 1.059 (0.960–1.167) | 0.251 | 1.024 (0.921–1.139) | 0.660 | 0.996 (0.857–1.158) | 0.961 | 0.958 (0.813–1.130) | 0.612 |
Tumor size | 1.005 (1.003–1.008) | 0.000 | 1.006 (1.003–1.008) | 0.000 | 1.007 (1.003–1.012) | 0.000 | 1.009 (1.005–1.014) | 0.000 |
Regional LN positive | 1.034 (1.014–1.054) | 0.001 | 1.040 (1.019–1.062) | 0.000 | 1.053 (1.020–1.087) | 0.002 | 1.069 (1.033–1.107) | 0.000 |
Regional LN examined | 0.995 (0.987–1.004) | 0.261 | 0.993 (0.984–1.002) | 0.136 | 0.994 (0.981–1.007) | 0.370 | 0.988 (0.973–1.003) | 0.121 |
% of LN positive | 1.902 (1.490–2.429) | 0.000 | 1.965 (1.507–2.562) | 0.000 | 1.562 (1.041–2.342) | 0.031 | 1.560 (0.997–2.439) | 0.051 |
Histology (versus Adenocarcinoma) | ||||||||
Squamous cell carcinoma | 1.183 (1.058–1.323) | 0.003 | 1.133 (1.002–1.282) | 0.046 | 1.278 (1.077–1.516) | 0.005 | 1.213 (1.004–1.467) | 0.045 |
Adenosquamous and Large cell carcinoma | 1.278 (1.069–1.527) | 0.007 | 1.300 (1.073–1.575) | 0.007 | 1.256 (0.964–1.637) | 0.092 | 1.335 (1.007–1.771) | 0.045 |
Differentiation grade (versus Well differentiated) | ||||||||
Moderately differentiated | 1.118 (0.901–1.387) | 0.310 | 1.149 (0.906–1.458) | 0.251 | 1.051 (0.703–1.570) | 0.809 | 1.117 (0.717–1.741) | 0.625 |
Poorly differentiated | 1.245 (1.002–1.546) | 0.048 | 1.284 (1.011–1.631) | 0.041 | 1.168 (0.781–1.745) | 0.449 | 1.238 (0.794–1.929) | 0.346 |
Undifferentiated | 1.371 (0.969–1.942) | 0.075 | 1.377 (0.940–2.018) | 0.101 | 1.434 (0.799–2.571) | 0.227 | 1.526 (0.809–2.880) | 0.192 |
Surgical procedure (versus Sublobectomy) | ||||||||
Lobectomy | 0.786 (0.664–0.930) | 0.005 | 0.769 (0.641–0.922) | 0.005 | 0.659 (0.500–0.868) | 0.003 | 0.613 (0.456–0.825) | 0.001 |
Pneumonectomy | 0.778 (0.619–0.978) | 0.032 | 0.757 (0.590–0.970) | 0.028 | 0.515 (0.344–0.771) | 0.001 | 0.487 (0.315–0.753) | 0.001 |
T stage (sixth edition) (versus T1) | ||||||||
T2 | 1.224 (1.090–1.375) | 0.001 | 1.224 (1.078–1.390) | 0.002 | 1.165 (0.971–1.397) | 0.100 | 1.160 (0.950–1.417) | 0.145 |
T3 | 1.816 (1.477–2.233) | 0.000 | 1.960 (1.574–2.440) | 0.000 | 1.747 (1.249–2.443) | 0.001 | 1.812 (1.263–2.598) | 0.001 |
PORT (versus No PORT) | 0.846 (0.769–0.932) | 0.001 | 0.838 (0.755–0.931) | 0.001 | 0.793 (0.690–0.912) | 0.001 | 0.837 (0.719–0.975) | 0.022 |